Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Acetyl-CoA carboxylase inhibitors, their preparation and use claimed by Ajinomoto

Sep. 4, 2003

Beneficial effects described for inhaled insulin in type 2 diabetes

Sep. 4, 2003

Shionogi patent describes new antidiabetic agents

Sep. 4, 2003

Novel cathepsin K inhibitors in GSK development pipeline

Sep. 4, 2003

Rapid absorption and onset of action for insulin glulisine in dogs and humans

Sep. 4, 2003

Mechanism of action of CKD-501, a new thiazolidinedione derivative

Sep. 3, 2003

European approval obtained for Actos

Sep. 3, 2003

Therapeutic utility of BIM-51077 in diabetes investigated in ZDF rats

Sep. 3, 2003

Chemically novel inhibitor of GSK3 with potential in type 2 diabetes

Sep. 3, 2003

New agents for thrombopenia therapy in early development at Yamanouchi

Sep. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...